Alibaba Buying South China Morning Post, Aiming to Influence Media
The Chinese Internet giant said the deal was fueled by a desire to improve China’s image and offer an alternative to the biased lens of Western news outlets.
News: Morning Agenda: Avon Said to Discuss Selling North American Business
Fired JPMorgan Broker Says Complaints Written by Bank, Not Clients | Uber Valued at $ 62.5 Billion
News: Morning Agenda: Pfizer’s War on Taxation
New Banking Rules for New York | Court Upholds Award Against RBC Capital | New Fed Rule Limits Emergency Lending
News: Morning Agenda: The Powerful Development Bank at the Center of Puerto Rico’s Woes
Pfizer Didn’t Need Inversion to Avoid Taxes | BTG Chief Steps Down
News: Morning Agenda: Treasury Secretary Warns Foes of Dodd-Frank
Calpers Reveals Private Equity Fees and Profits | A Season of Silly Deal-Making | Bureacracy Ends Experimental Credit Union
News: Morning Agenda: Pfizer-Allergan Deal Revives Debate Over U.S. Taxes
Elliott Adds a Chief Executive | Ackman Raises Stake in Valeant | Diller’s Minifactory of Spinoffs Pays Off
News: Morning Agenda: Pfizer and Allergan Reach 0 Billion Deal
Puerto Rico’s Creditors Open to Debt Exchange | Petco Close to $ 4.7 Billion Sale to CVC and Canadian Pension Fund
News: Morning Agenda: New Proposals to Curb Tax Relocations
Banks Weighed Down by Piles of Leveraged Loans | Buffett’s Grandson Seeks a Different Investment Route | Square Shares Soar After Public Offering
News: Morning Agenda: Square Scales Down Valuation
Pfizer and Allergan Are Said to Be Near a Deal | Fed Signals Readiness for December Rate Rise
News: Morning Agenda: Lyft Is Said to Seek 0 Million
Appetite for Risky Loans Wanes | Air Liquide to Acquire Airgas | Canadian Pacific Takes Merger Bid to Norfolk Southern
News: Morning Agenda: Stocks Fall After Paris Attacks
Campaign Against Efforts to Restrict Arbitration | An Irresistible Tax Move for Pfizer | Two Competing Drugs and Billion-Dollar Questions
News: Morning Agenda: Anheuser-Busch InBev Finalizes SABMiller Deal
Dizzying Ride May Be Ending for Start-Ups | No Clear Answer on Director Pay | More Charges in Online Attack at JPMorgan
News: Morning Agenda: Ackman Defiant Over Valeant
Pimco Suit Highlights Murky Investor Fees | Canadian Pacific Said to Weigh Norfolk Southern Deal | Match Seeks $ 3.1 Billion Valuation
News: Morning Agenda: Bonus Pay on Wall Street Likely to Fall
A Tough Year for Hedge Funds, but Not Real Estate | Square Persists with I.P.O.
News: Morning Agenda: Former Traders Found Guilty in Libor Case
Goldman Tries New Policies to Keep Its Junior Bankers | Allergan Plays Coy Over Pfizer Talks
News: Morning Agenda: The Bitcoin Resurgence
Interest Rate Increase in December Is Still Possible | A 1975 Law Complicates Puerto Rico’s Debt Crisis | Activists May Not Be That Myopic
News: Morning Agenda: Success of Goldman-Funded School Program Questioned
Regulators Unbundle Attractions of Mergers | Japan Post Makes a Strong Market Debut
News: Morning Agenda: Activision Blizzard to Buy Maker of Candy Crush
Religious Arbitration Used for Secular Disputes | Soros Withdraws $ 490 Million From Janus Capital
News: The Morning Agenda: The Privatization of the Justice System
Lessons in Investing From Valeant | HSBC Profit Jumps